Drug-eluting stents with biodegradable polymer for the treatment of patients with diabetes mellitus: clinical outcome at 2 years in a large population of patients
Marcus Wiemer,1 Gian Battista Danzi,2 Nick West,3 Vassilios Voudris,4 René Koning,5 Stefan Hoffmann,6 Mario Lombardi,7 Josepa Mauri,8 Rade Babic,9 Fraser Witherow10On behalf of the NOBORI 2 Investigators 1Department of Cardiology, Heart and Diabetes Center North Rhine–Westphali...
Guardado en:
Autores principales: | Wiemer M, Danzi GB, West N, Voudris V, Koning R, Hoffmann S, Lombardi M, Mauri J, Babic R, Witherow F |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/14e425105f1b4488962ea55d1d4aa157 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Biodegradable polymer Biolimus-eluting stent (Nobori®) for the treatment of coronary artery lesions: review of concept and clinical results
por: Schurtz G, et al.
Publicado: (2014) -
Next generation drug-eluting stents: focus on bioabsorbable platforms and polymers
por: Brendan Doyle, et al.
Publicado: (2009) -
Everolimus-eluting coronary stents
por: Alejandro Saez, et al.
Publicado: (2010) -
Everolimus-eluting stents: update on current clinical studies
por: Allocco DJ, et al.
Publicado: (2011) -
Long-term effectiveness and safety of sirolimus drug-eluting stents
por: Bikkina M, et al.
Publicado: (2011)